
AbCellera Biologics Hits Day Low of $3.42 Amid Price Pressure
2025-11-10 17:53:36AbCellera Biologics, Inc. faced notable stock volatility on November 7, 2025, with a significant decline amid contrasting market performance. The company has struggled with negative results over the past ten quarters, low liquidity indicators, and a market capitalization of USD 1,246 million, classifying it as a small-cap entity.
Read full news article
AbCellera Biologics Hits Day Low of $4.67 Amid Price Pressure
2025-11-06 16:20:08AbCellera Biologics, Inc. faced a notable decline in stock value, contrasting with the broader market's performance. Despite recent setbacks and negative results over ten quarters, the company has shown strong year-over-year growth. Institutional investors maintain significant holdings, indicating ongoing confidence in its fundamentals amid current challenges.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






